Search for: "K-V Pharmaceutical Company"
Results 61 - 80
of 221
Sorted by Relevance
|
Sort by Date
4 Oct 2019, 10:27 am
OSI Pharma v. [read post]
29 Sep 2009, 11:38 am
In Re ‘318 Patent Infringement Litigation (a/k/a Janssen Pharma and Synaptech v. [read post]
3 Jun 2016, 6:40 am
Michelle K. [read post]
7 Jan 2013, 12:12 pm
That left the claims against the pharmaceutical companies. [read post]
8 Sep 2014, 4:55 am
This one is Chanel Inc. v Chanel’s Salon and Chanel Jones, 2:14-cv-00304, and sees fashion and cosmetics company Chanel as plaintiff. [read post]
20 Jan 2016, 8:00 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
12 Jan 2016, 11:39 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
15 May 2012, 3:12 pm
However, the Commission scrapped such investigations into AstraZeneca and Swiss peer Nycomed in March this year after failing to find evidence that the companies had undertaken such deals. [read post]
24 Apr 2017, 11:12 am
Subsection (l) provides a process by which the applicant for a biosimilar license (i.e., the generic pharmaceutical company) can exchange information about patents with the company that first obtained FDA approval to market the original biologic drug (i.e., the research pharmaceutical company). [read post]
7 Apr 2013, 7:26 pm
Lee (Kenyon & Kenyon) noted that both brand-name pharmaceutical companies and generics want reverse payments to continue. [read post]
1 Jan 2016, 9:00 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Mar 2016, 5:19 am
Novartis Pharmaceuticals Corp., 247 P.3d 244, 257 (Mont. 2010); Downing v. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
17 Feb 2016, 9:20 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
24 Apr 2010, 5:05 am
Mary K. [read post]
3 May 2016, 1:42 am
Michelle K. [read post]
18 Apr 2016, 9:58 am
Michelle K. [read post]
27 Apr 2020, 2:00 am
On Wednesday 29 April 2020, the Supreme Court will hear the appeal of The Advocate General representing the Commissioners of HMRC v K E Entertainments Ltd (Scotland) .This appeal will consider whether the taxpayer (K E Entertainment Ltd)’s claim to a repayment of VAT fell within the scope of the Principal VAT Directive, Articles 73 and 90, together with (if necessary) VAT Regulation 38 (as the taxpayer contends) or within VAT Act section 80 and is therefore… [read post]
18 May 2016, 8:19 am
Michelle K. [read post]
